Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 237

Solazyme plans $100m flotation

Solazyme, a US-based developer of biofuels through the use of algae, said it had raised $129.3m in equity and its strategic investors were Bunge, Chevron, Unilever and San-Ei Gen ahead of its $100m flotation.

Mar 15, 2011

Fusion-io preps $150m flotation

Investment banks Goldman Sachs, Morgan Stanley, JP Morgan and Credit Suisse are underwriting Fusion-io's initial public offering, according to its regulatory filing.

Mar 11, 2011

Advanced BioHealing preps flotation

Safeguard owns 1.59 million shares, 28.1% of Advanced BioHealing ahead of its Nasdaq flotation, while venture capital firms Canaan Partners and Wheatley Partners own 40.7% and 14.7%, respectively.

Mar 1, 2011

Oak Pacific preps $500m flotation

Newswire Bloomberg said Oak's $500m initial public offering could come by the summer and was backed by computer group Lenovo's corporate venturing unit Legend Capital and Japanese media group Softbank as well as venture capital firms Technology Crossover Ventures, Accel Partners, and Doll Capital Management.

Feb 24, 2011

HomeAway preps flotation

Newswire Bloomberg said HomeAway's flotation would be for up to $300m and managed by investment banks Morgan Stanley, Deutsche Bank, JPMorgan Chase and Goldman Sachs.

Feb 23, 2011

Pandora Media preps flotation

In August, Pandora had been reportedly about to raise $100m from private equity firm Elevation Partners, according to news provider TechCrunch, but instead has picked investment banks Morgan Stanley and JP Morgan to plan its initial public offering, according to its regulatory filing.

Feb 16, 2011

Active Network stays fit for flotation

Active Network has raised more than $275m, according to news provider Fortune, and has Ticketmaster and Disney as two primary shareholders.

Feb 15, 2011

Fluidigm floats at range bottom

Fluidigm raised $75m at $13.50 per share by selling 5.6 million shares, with a further 833,750 available if demand is strong enough for its investment banks Deutsche Bank and Piper Jaffray, according to its regulatory filing.

Feb 13, 2011

AcelRx halves flotation

AcelRx had planned to raise $86m in its initial public offering (IPO) but is now offering eight million shares at $5 each, with a further 1.2 million available if there is enough demand, according to its regulatory filing.

Feb 13, 2011

Gevo fuels $100m flotation

The company sold 7.15 million common shares at its initial public offering (IPO) at $15 each, according to Gevo's regulatory filing.

Feb 13, 2011
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here